ZyVersa Therapeutics Inc. (ZVSA) — Defensive Interval Ratio

Latest as of December 2024: 49703 days

ZyVersa Therapeutics Inc. (ZVSA) has a Defensive Interval Ratio of 49703 days as of December 2024. Defensive assets of $1.53 Billion (cash $-, short-term investments $1.53 Billion, receivables $-) cover 49703 days of daily cash needs of $30.77K/day. See ZyVersa Therapeutics Inc. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

49703 days
Days of operational coverage

Defensive Assets

$1.53 Billion
Cash + ST Investments + Receivables

Daily Cash Need

$30.77K
Current Liabilities ÷ 365

Current Liabilities

$11.23 Million
USD

ZyVersa Therapeutics Inc. Defensive Interval Ratio (2024–2024)

This chart shows how ZyVersa Therapeutics Inc.'s Defensive Interval Ratio has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the ratio stands at 49703 days, meaning defensive assets of $1.53 Billion can fund 49703 days of operations without new revenue. See ZVSA equity to assets ratio to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for ZyVersa Therapeutics Inc. (2024–2024)

The table below presents the year-by-year Defensive Interval Ratio for ZyVersa Therapeutics Inc. from 2024 to 2024, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ZyVersa Therapeutics Inc. (ZVSA) market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 49703 days $1.53 Billion $30.77K/day $- $1.53 Billion
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)